The gene editing market was valued at $3.9 billion in 2021, and is estimated to reach $7.4 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.

PORTLAND, OREGON, UNITED STATES, August 9, 2022 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global Gene Editing Market was estimated at $3.9 billion in 2021, and is anticipated to hit $7.4 billion by 2031, registering a CAGR of 6.7% from 2022 to 2031. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and varying market trends.

Get Free Sample PDF of Gene Editing Market Report:
https://www.alliedmarketresearch.com/request-sample/11338

COVID-19 Impact Analysis on Gene Editing Market-

The Covid-19 outbreak had a positive impact on the gene editing market as it has driven biotechnology firms to invest in the gene editing space to develop rapid molecular diagnostic tests.
In search for new ways to combat SARS-CoV-2, the novel coronavirus that causes Covid-19, researchers are studying the potential of gene-modification tools such as CRISPR as a potential rapid screening solution for the COVID-19 genome.

Increased R&D expenditure in gene editing in BRICS countries, growth of the biotechnology and pharmaceutical industries, increase in private and public sector funding for gene editing, rapid advancements in sequencing and genome editing technologies, non-labelling of gene-edited products such as Genetically Modified Organisms (GMOs) and applications of gene editing in various drug discovery processes drive the growth of the global gene editing market. However, the high cost of genomic equipment is a factor that act as a restraint for the market growth. Moreover, the growing demand for synthetic genes for medicine development to cure cancer is expected to provide opportunities for the growth of the gene editing market in future.

Gene editing also known as genome editing, is a field of study that aims to modify genes in live animals in order to better understand gene function and create treatments for hereditary and acquired disorders. In many different types of cells and species, genome editing can be used to fix, introduce, or delete practically any DNA sequence. While DNA editing techniques have been around for decades, new ways have made it faster, cheaper, and more efficient. The revelation that a broken portion of DNA in a gene stimulates a cell's repair system to patch the split together led to the development of genome editing. Researchers can use genome editing to replicate the natural process of DNA repair. Zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and meganucleases are advanced genome editing technologies based on proteins. Another approach is CRISPR/Cas9, which stands for clustered regularly interspaced short palindromic repeats.

In gene editing market trends CRISPR/Cas9 is the most extensively used genome editor, and it's a great way to figure out how genes work. Because CRISPR/Cas9 is an RNA-based system, it can be tweaked more quickly and easily than protein-based systems, and it can target many locations. CRISPR was discovered as a result of fundamental research financed by the National Institutes of Health into how bacteria defend themselves against viruses. CRISPR/Cas9 changes a single base pair of DNA, vast chunks of chromosomes, or gene expression regulation by cutting a DNA sequence at a specified genetic region and deleting or inserting DNA sequences these are the factors growing the market in gene editing market forecast period.

Ask more about Gene Editing Market Report:
https://www.alliedmarketresearch.com/purchase-enquiry/11338

Depending on application, the gene editing market share is segmented into gene editing, cell line engineering, animal genetic engineering, plant genetic engineering, drug development, and others. The others segment is further classified into bioenergy, diagnosis, cell and gene therapies, microorganisms genetic engineering, drug discovery, GMO (genetically modified organisms), vaccine development, and basic research. The gene editing segment dominated the market in 2021 with a revenue of $1,123.16 million and is expected to grow with the highest CAGR of 8.2%. Growth of the segment is attributed to surge in clinical diagnosis and medical research.

By end user, the gene editing market size is fragmented into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations. The biotechnology and pharmaceutical companies segment dominated the market in 2021 with a revenue of $2,311.49 million. In gene editing market size, growth of the largest growing segment is attributed to increase in funding in R&D for drug development and cancer treatments. Academic and government institutes are expected to grow with the highest CAGR of 7.2% during the forecast period.
Region-wise, in gene editing industry, North America accounted for more than 6.6% of the global market share in 2021 with largest revenue of $1,723.2 million, during the forecast period. This was attributed to surge in cases of cancer and genetic disorders. Asia-Pacific is projected to register the highest CAGR of 7.7% during the forecast period, owing to surge in medical and clinical advancements.

Buy Now with Discount (Till 20th August 2022):
https://www.alliedmarketresearch.com/checkout-final/2974e7b4132b0641441014694028f430

The key players analyzed in the global gene editing market include Addgene, Allele Biotech, Bio-Rad Laboratories, CRISPR Therapeutics, General Electric, OriGene Technologies, Precision Biosciences, Takara Biotech, Thermofischer Scientific Inc., and Transposagen Biopharma Inc.

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn